reports
Macrogen Licenses Gene Editing Technology from Broad Institute of MIT ...
SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com) (KOSDAQ: 038290), a precision medicine biotechnology company, announced on April 5 that it has acquired a non-exclusive commercial research tool license to CRISPR-Cas9 technology from the Broad Institute of MIT and Harvard in the USA, and said that the company’s gene editing technical portfolio has been further strengthened by licensing of this technology. Macrogen has acquired around 50 technologies, including the CRISPR-Cas9 portfolio...
Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation
ROCKVILLE, Md.--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. “Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhav...
Le laboratoire d’analyses NGS de Macrogen Corp. reçoit l’accré...
ROCKVILLE, Maryland--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) annonce que son laboratoire d’analyses qui fournit des services cliniques NGS a été accrédité par le Comité d’accréditation du College of American Pathologists (CAP), suite aux résultats d’une récente inspection effectuée sur place dans le cadre des Programmes d’accréditation, du CAP. « Macrogen témoigne de son leadership, de ses innovations et de son engagement passionné à respecter les normes d’excellence tout en fournissant des services de q...
Macrogen Established Its Branch in Spain, Strengthening Localization S...
SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sept. 4 that it will begin providing localization service in September at its branch in Madrid, Spain. The Spanish branch of Macrogen was established last December following its first European branch in Amsterdam, Netherlands. This branch will provide quick and customer-friendly services to Southern Europe and the MENA (Middle East and North Africa) area t...
Macrogen a établi une succursale en Espagne, afin de renforcer son se...
SÉOUL, Corée du Sud--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ : 038290), une société de biotechnologie médicale de précision, a annoncé le 4 septembre que dès septembre elle offrirait, depuis sa succursale de Madrid en Espagne, un service de localisation. La succursale espagnole de Macrogen a été créée en décembre dernier après l’ouverture de sa première branche européenne à Amsterdam, aux Pays-Bas. Cette succursale fournira des services rapides et adaptés aux clients du sud de ...
Macrogen Launches Special Promotion on Exome Sequencing to Celebrate T...
SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on June 1st that it is launching a special promotion on Exome Sequencing to celebrate their 20th anniversary. During this special promotion period, Macrogen will offer Exome Sequencing service with 100x coverage using SureSelect Human All Exon V5 (50M) or V6 (58M) capture kit at a special price of $299 per sample. This is an innovative price that has never be...
Macrogen lance une promotion spéciale du séquençage de l'exome pour...
SÉOUL, Corée du Sud--(BUSINESS WIRE)-- Macrogen Inc. (PDG Hyon-yong Chong, www.macrogen.com) (KOSDAQ : 038290), une société biotechnologique de médecine de précision, a annoncé le 1er juin qu'elle lançait une promotion spéciale sur le séquençage de l'exome pour célébrer son 20e anniversaire. Durant cette période de promotion spéciale, Macrogen offrira le service de séquençage de l'exome avec une couverture 100x en utilisant le kit de capture SureSelect Human All Exon V5 (50M) ou V6 (58M) au prix spécial de 299 USD par échan...
Macrogen Leads Precision Medicine by Advancing the Realization of the ...
SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyun-yong Jeong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on March 28 that it completed the installation of the NovaSeq 6000, the latest equipment for genetic analysis by Illumina Inc., on the network of the Macrogen Global Genome Center. The NovaSeq 6000 is a sequencing system Illumina introduced at the JP Morgan Healthcare Conference last January, foretelling the “$100 Genome Age.” This high-tech equipment, a new platfor...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Macrogen Launches 'Easybox', a Premium Temperature-Controlled Package
SEOUL, South Korea--(BUSINESS WIRE)-- The precision medicine biotechnology enterprise Macrogen (CEO Hyeon-yong Jeong, www.macrogen.com)(KOSDAQ:038290) announced today its new premium temperature-controlled packaging named ‘Easybox’ for customers in the gene and genome analytics service industry worldwide. The customized premium temperature-controlled packaging option was developed by Macrogen, and its delivery speed and reliability were enhanced thanks to an express shipping service by FedEx Express (FedEx), the world’...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.